Medipal Holdings Overview

  • Year Founded
  • 1898

Year Founded

  • Status
  • Public

  • Employees
  • 24,096

Employees

  • Stock Symbol
  • 7459

Stock Symbol

  • Investments
  • 32

  • Share Price
  • $20.19
  • (As of Friday Closing)

Medipal Holdings General Information

Description

Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.

Contact Information

Formerly Known As
MEDICEO Holdings, Mediceo Paltac Holdings
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 3-1-1 Kyobashi
  • Chuo-ku
  • Tokyo, 104-8461
  • Japan
+81
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Stock Exchange
TKS
Vertical(s)
Corporate Office
  • 3-1-1 Kyobashi
  • Chuo-ku
  • Tokyo, 104-8461
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medipal Holdings Stock Performance

As of 13-Nov-2026, Medipal Holdings’s stock price is $20.19. Its current market cap is $4.13B with 205M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$20.19 $20.02 $15.73 - $22.78 $4.13B 205M 514K $1.35

Medipal Holdings Financials Summary

As of 30-Sep-2026, Medipal Holdings has a trailing 12-month revenue of $24.7B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 31-Mar-2026 FY 2025 31-Mar-2025 FY 2024 31-Mar-2024
EV 2,905,415 2,929,171 2,498,477 2,651,540
Revenue 24,712,912 25,326,628 24,074,579 24,629,635
EBITDA 623,381 657,237 615,135 634,308
Net Income 276,210 282,196 264,128 287,037
Total Assets 12,527,874 12,023,183 12,195,638 11,887,196
Total Debt 917,315 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medipal Holdings Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medipal Holdings‘s full profile, request access.

Request a free trial

Medipal Holdings Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and rel
Drug Delivery
Tokyo, Japan
24,096 As of 2026

Nagoya, Japan
 

Osaka, Japan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medipal Holdings Competitors (5)

One of Medipal Holdings’s 5 competitors is Suzuken, a Corporation company based in Nagoya, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Suzuken Corporation Nagoya, Japan
ONO Pharmaceutical Corporation Osaka, Japan
Otsuka Holdings Corporation Tokyo, Japan
Nipro Corporation Osaka, Japan
Taisho Pharmaceutical Indonesia Corporation Jakarta, Indonesia
You’re viewing 5 of 5 competitors. Get the full list »

Medipal Holdings Patents

Medipal Holdings Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026095904-A Information processing device, information processing method, and program Pending 02-Dec-2024
JP-2026029063-A Container instrument for freezing target object Active 08-Aug-2024
WO-2026034089-A1 Frozen object accommodation device Pending 08-Aug-2024
JP-7781986-B1 Storage device for frozen objects Active 08-Aug-2024
JP-2025111998-A Information processing system and information processing method Pending 18-Jan-2024
To view Medipal Holdings’s complete patent history, request access »

Medipal Holdings Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medipal Holdings Investments & Acquisitions (32)

Medipal Holdings’s most recent deal was a Early Stage VC with Mutex for . The deal was made on 30-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mutex 30-Sep-2026 Early Stage VC Business/Productivity Software
Metagen Therapeutics 04-Sep-2026 Later Stage VC Drug Discovery
MC Healthcare Group 07-Aug-2026 Merger/Acquisition Distributors (Healthcare)
Paltac 08-Jul-2026 Secondary Transaction - Private Distributors/Wholesale
Holoeyes 03-Jun-2025 Later Stage VC Medical Records Systems
You’re viewing 5 of 32 investments and acquisitions. Get the full list »

Medipal Holdings ESG

Risk Overview

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Distribution

Subindustry

Rank

Percentile

To view Medipal Holdings’s complete esg history, request access »

Medipal Holdings Exits (7)

Medipal Holdings’s most recent exit was on 03-Jun-2025 from Holoeyes. The exit was categorized as with 12 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Holoeyes 03-Jun-2025 Completed
  • 12 buyers
Aculys 11-Feb-2025 Completed
  • 4 buyers
Chordia Therapeutics 13-May-2022 Completed
  • 9 buyers
Heartseed 11-Jun-2021 Completed
  • 9 buyers
Heartseed 10-Mar-2020 Later Stage VC Completed
You’re viewing 5 of 7 exits. Get the full list »

Medipal Holdings Affiliates

Subsidiaries (15)

Name Industry Location Year Founded
Medipal Innovation Tokyo, Japan 2021
Falfield Koto City, Japan 2020
Qol Company Tokyo, Japan 2017
Presus Cube Tokyo, Japan 2016
Doctorbook Tokyo, Japan 2013
You’re viewing 5 of 15 affiliates. Get the full list.  »

Medipal Holdings FAQs

  • When was Medipal Holdings founded?

    Medipal Holdings was founded in 1898.

  • Where is Medipal Holdings headquartered?

    Medipal Holdings is headquartered in Tokyo, Japan.

  • What is the size of Medipal Holdings?

    Medipal Holdings has 24,096 total employees.

  • What industry is Medipal Holdings in?

    Medipal Holdings’s primary industry is Drug Delivery.

  • Is Medipal Holdings a private or public company?

    Medipal Holdings is a Public company.

  • What is Medipal Holdings’s stock symbol?

    The ticker symbol for Medipal Holdings is 7459.

  • What is the current stock price of Medipal Holdings?

    As of 13-Nov-2026 the stock price of Medipal Holdings is $20.19.

  • What is the current market cap of Medipal Holdings?

    The current market capitalization of Medipal Holdings is $4.13B.

  • What is Medipal Holdings’s current revenue?

    The trailing twelve month revenue for Medipal Holdings is $24.7B.

  • Who are Medipal Holdings’s competitors?

    Suzuken, ONO Pharmaceutical, Otsuka Holdings, Nipro, and Taisho Pharmaceutical Indonesia are competitors of Medipal Holdings.

  • What is Medipal Holdings’s annual earnings per share (EPS)?

    Medipal Holdings’s EPS for 12 months was $1.35.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process